4.6 Article

Characteristics of Classical Swine Fever Virus Variants Derived from Live Attenuated GPE- Vaccine Seed

期刊

VIRUSES-BASEL
卷 13, 期 8, 页码 -

出版社

MDPI
DOI: 10.3390/v13081672

关键词

classical swine fever virus; GPE(-); live attenuated vaccine; vaccine seed; variant; NS5B; type I interferon

类别

资金

  1. Ministry of Agriculture, Forestry and Fisheries of Japan [JPJ008617.20319390]
  2. Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (MEXT KAKENHI) [JP19H03115]

向作者/读者索取更多资源

The GPE(-) strain is a live attenuated vaccine for classical swine fever developed in Japan, with a vGPE(-) clone showing good potential despite some amino acid substitutions in the original seed. Replication-competent GPE(-) seed variant clones were produced, though their interferon-inducing capacity was lower than vGPE(-).
The GPE(-) strain is a live attenuated vaccine for classical swine fever (CSF) developed in Japan. In the context of increasing attention for the differentiating infected from vaccinated animals (DIVA) concept, the achievement of CSF eradication with the GPE(-) proposes it as a preferable backbone for a recombinant CSF marker vaccine. While its infectious cDNA clone, vGPE(-), is well characterized, 10 amino acid substitutions were recognized in the genome, compared to the original GPE(-) vaccine seed. To clarify the GPE(-) seed availability, this study aimed to generate and characterize a clone possessing the identical amino acid sequence to the GPE(-) seed. The attempt resulted in the loss of the infectious GPE(-) seed clone production due to the impaired replication by an amino acid substitution in the viral polymerase NS5B. Accordingly, replication-competent GPE(-) seed variant clones were produced. Although they were mostly restricted to propagate in the tonsils of pigs, similarly to vGPE(-), their type I interferon-inducing capacity was significantly lower than that of vGPE(-). Taken together, vGPE(-) mainly retains ideal properties for the CSF vaccine, compared with the seed variants, and is probably useful in the development of a CSF marker vaccine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据